SPRINGFIELD — State Senator Julie Morrison is spearheading efforts to tackle the rise in dangerous synthetic drug abuse in Illinois by classifying xylazine — a powerful animal tranquilizer often mixed with fentanyl — as a controlled substance while protecting legal veterinary usage.

“Too many families have lost loved ones to synthetic opioid usage, and xylazine is making these drugs even deadlier,” said Morrison (D-Lake Forest). “This bill reflects a proactive step in addressing a crisis that touches every corner of our state.”

Senate Bill 1773 would update the state’s controlled substance classifications to better address emerging drug trends, such as the mixing of fentanyl and xylazine. The bill, an initiative of the Illinois State Police, aims to provide law enforcement with more effective tools to combat the evolving challenges posed by illicit drug use. It would categorize xylazine as a Schedule III controlled substance and clear up legal definitions to align Illinois law with federal standards, preventing loopholes that could put people at risk.

Xylazine, also known as “tranq,” is not intended for human use and has been linked to a rising number of overdose deaths. While xylazine poses a risk when misused, it is an FDA-approved animal sedative used by veterinarians, euthanasia technicians and wildlife biologists. Senate Bill 1773 includes exemptions to ensure these professionals can continue to use the substance in approved and regulated ways, such as surgery and pain relief in large animals.

“It’s time to act to keep this dangerous drug out of the wrong hands while protecting the professionals who use it in their line of work,” said Morrison. “Through this legislation, we are striking a balance between public safety and responsible animal care.”

Senate Bill 1773 passed the Senate Criminal Law Committee with bipartisan support on Wednesday and awaits further action in the Senate.

-30-